↓ Skip to main content

The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

Overview of attention for article published in BMC Cancer, July 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

peer_reviews
1 peer review site
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
66 Dimensions

Readers on

mendeley
29 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
Published in
BMC Cancer, July 2006
DOI 10.1186/1471-2407-6-195
Pubmed ID
Authors

AM Havens, Y Jung, YX Sun, J Wang, RB Shah, HJ Bühring, KJ Pienta, RS Taichman

Abstract

The chemokine stromal derived factor-1 (SDF-1 or CXCL12) and its receptor CXCR4 have been demonstrated to be crucial for the homing of stem cells and prostate cancers to the marrow. While screening prostate cancers for CXCL12-responsive adhesion molecules, we identified CD164 (MGC-24) as a potential regulator of homing. CD164 is known to function as a receptor that regulates stem cell localization to the bone marrow.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Italy 1 3%
Germany 1 3%
Unknown 26 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 24%
Student > Master 6 21%
Professor 5 17%
Researcher 2 7%
Student > Bachelor 1 3%
Other 4 14%
Unknown 4 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 34%
Medicine and Dentistry 7 24%
Biochemistry, Genetics and Molecular Biology 4 14%
Immunology and Microbiology 1 3%
Social Sciences 1 3%
Other 3 10%
Unknown 3 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2021.
All research outputs
#6,406,498
of 22,760,687 outputs
Outputs from BMC Cancer
#1,632
of 8,277 outputs
Outputs of similar age
#20,201
of 65,595 outputs
Outputs of similar age from BMC Cancer
#4
of 17 outputs
Altmetric has tracked 22,760,687 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 8,277 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,595 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.